The present invention relates to polymer nanoparticles, methods for their preparation, and their use as, for example, templates for the formation of nano-sized metal/inorganic crystals and nanocomposites.
Nanoparticles have attracted increased attention over the past several years in a variety of fields including catalysis, combinatorial chemistry, protein supports, magnets, and photonic crystals. Nano-scale metal composites have also been used advantageously in a variety of fields including, but not limited to, information technology, medicine and health, material and manufacturing, aeronautics and space exploration, environmental, energy fields, and snow/wet traction improvement for tire rubbers. Formation of nano-scale metal composites has often proven difficult due to the expense and difficulty of creating known templates, as well as the often difficult step of separating the composites from the template.
Accordingly, it would be desirable to develop polymer nano-micelle particles with desirable core and surface characteristics and size. It would also be desirable to develop a process for using these nanoparticles as templates to produce nano-scale metal composites and nano-sized metal/inorganic crystals in pure form.
In one embodiment of the present invention, a method for forming a polymer nano-micelle particle is provided. The method includes forming a copolymer comprising alkenyl monomer units and maleimide monomer units in a dry state, placing the copolymer into a non-polar solvent, and allowing the copolymer chains to form micelles.
In another embodiment, a method for forming metal nanocomposites is provided. The method includes forming a copolymer comprising alkenyl monomer units and alkyl maleimide monomer units in a dry state, placing the copolymer into a non-polar solvent and allowing the copolymer chains to form micelles. At least one metal in solution is added to the solvent containing micelles, thereby allowing the metal to complex with the copolymer chains in the desired concentrations, forming the metal nanocomposites.
A third embodiment, the present invention provides a method comprised of dissolving the polymer particles in a suitable solvent, thereby obtaining nano-sized metal/inorganic crystals in pure form, and regenerating the polymer.
The following definitions apply herein throughout unless a contrary intention is expressly indicated:
where R1 and R2 are the same or different substituents on the same or different carbon atoms of the ethylene group, and are independently H or substituted C1-C20 alkyl groups; and
One exemplary polymer nanoparticle of the present invention is formed from polymer chains. Preferred polymers include alkylmaleimides. The copolymers are preferably poly(alkenyl-co-maleimide)s and may optionally be crosslinked to form the desired polymer nanoparticles. The polymer nanoparticles have diameters—expressed as a mean average diameter—that are preferably less than about 100 nm, more preferably less than about 75 nm, and most preferably less than about 50 nm. The polymer nanoparticles preferably are substantially monodisperse and uniform in shape. The dispersity is represented by the ratio of Mw to Mn, with a ratio of 1 being substantially monodisperse. The polymer nanoparticles of the present invention preferably have a dispersity less than about 2.5, more preferably less than about 2.2, and most preferably less than about 1.8. Moreover, the polymer nanoparticles are preferably spherical, though shape defects are acceptable. The formation of polymer nanoparticles is preferably reversible. The reversible process can be achieved by, for example, changing solvent, varying temperature, or altering pH value etc.
The poly(alkenyl-co-maleimide)s contain alkenyl contributed monomer units chosen from vinyl-substituted aromatic hydrocarbon, R1R2-ethylene, and/or alkyl vinyl ether. The copolymer further includes maleimide contributed monomer units.
Poly(alkenyl-co-maleimide)s and poly(alkenyl-co-maleic anhydride)s encompass random and stereospecific copolymers, including copolymers having a backbone with alternating alkenyl-contributed units (i.e., monomer units derived from an alkenyl group such as styrene) and maleimide- or maleic anhydride-contributed units (i.e., monomer units derived from a maleimide or a maleic anhydride). Such alternating structures typically are described as poly(alkenyl-alt-maleimide)s and poly(alkenyl-alt-maleic anhydride)s; however, these polymers are encompassed within the terms poly(alkenyl-co-maleimide)s and poly(alkenyl-co-maleic anhydride)s. Exemplary copolymers include copolymers with a ratio of about 50% alkenyl contributed monomer units and about 50% maleimide contributed monomer units. However, copolymers with at least about 20% alkenyl contributed monomer units are also contemplated for use.
Preferred vinyl-substituted aromatic hydrocarbon contributed monomer units of a poly(alkenylbenzene-co-maleimide) are preferably derived from one or more of styrene, α-methylstyrene, 1-vinyl-naphthalene, 2-vinyl-naphthalene, 1-α-methyl vinyl naphthalene, 2-α-methyl naphthalene, as well as alkyl, cycloalkyl, aryl, alkaryl, and aralkyl derivatives thereof, in which the total number of carbon atoms in the combined hydrocarbon is generally not greater than 18, as well as any di- or tri-vinyl aromatic hydrocarbons. Preferred vinyl aromatic hydrocarbons include styrene and/or α-methyl styrene.
Preferred R1 and R2 groups of R1R2-ethylene contributed monomer units and the alkyl groups of said alkyl vinyl ether contributed monomer units are independently selected from methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, cyclopropyl, 2,2-dimethylcyclopropyl, cyclopentyl, cyclohexyl, methoxymethyl, methoxyethyl, methoxypropyl, methoxybutyl, methoxypentyl, methoxyhexyl, methoxyoctyl, methoxynonyl, ethoxydecyl, ethoxymethyl, ethoxyethyl, ethoxypropyl, ethoxybutyl, ethoxypentyl, ethoxyhexyl, ethoxyheptyl, ethoxyoctyl, ethoxynonyl, ethoxydecyl, propoxymethyl, propoxyethyl, propoxypropyl, propoxybutyl, propoxypentyl, propoxyheptyl, propoxyoctyl, propoxynonyl, propoxydecyl, butoxymethyl, butoxyethyl, butoxypropoyl, butoxybutyl, butoxypentyl, butoxyhexyl, butoxyheptyl, butoxyoctyl, butoxynonyl, butoxydecyl, pentyloxymethyl, pentyloxyethyl, pentyloxypropyl, pentyloxybutyl, pentyloxypentyl, pentyloxyhexyl, pentyloxyoctyl, pentyloxynonyl, pentyloxydecyl, hexyloxymethyl, hexyloxyethyl, hexyloxypropyl, hexyloxybutyl, hexyloxypentyl, hexyloxyhexyl, hexyloxyheptyl, hexyloxyoctyl, hexyloxynonyl, hexyloxydecyl, heptyloxymethyl, heptyloxyethyl, heptyloxypropyl, heptyloxybutyl, hexyloxypentyl, heptyloxyhexyl, heptyloxyheptyl, heptyloxyoctyl, heptyloxynonyl, heptyloxydecyl, octyloxymethyl, octyloxyethyl, octyloxypropyl, octyloxybutyl, octyloxypentyl, octyloxyhexyl, octyloxyheptyl, octyloxyoctyl, octyloxynonyl, decyloxymethyl, decyloxyethyl, decyloxypropyl, decyloxybutyl, decyloxypentyl, decyloxyhexyl, decyloxyheptyl, 1-methylethyl, 1-methylpropyl, 1-methylbutyl, 1-methylpentyl, 1-methylhexyl, 1-methylheptyl, 1-methyloctyl, 1-methylnonyl, 1-methyldecyl, 2-methylpropyl, 2-methylbutyl, 2-bethylpentyl, 2-methylhexyl, 2-methylheptyl, 2-methyloctyl, 2,3,3-trimethylbutyl, 3-methylpentyl, 2,3-dimethylpentyl, 2,4-dimethylpentyl, 2,3,3,4-tetramethylpentyl, 3-methylhexyl, or 2,5-dimethylhexyl.
Preferred R1R2-ethylene contributed monomer units of the poly(R1R2-ethylene-co-maleimide) include alkenes such as ethylene, propylene, butylene, isobutylene, pentene, hexene, heptene, etc., as well as any di- or tri-alkene, or mixtures thereof, with preference given to isobutylene.
Preferred alkyl vinyl ether contributed monomer units of the poly(alkyl vinyl ether-co-maleimide) include any alkyl vinyl ether such as methyl vinyl ether, ethyl vinyl ether, propyl vinyl ether, butyl vinyl ether, and any other alkyl vinyl ether wherein the number of carbons in the alkyl substituent is not greater than about 30, and mixtures thereof. A preferred alkyl vinyl ether is methyl vinyl ether.
The poly(alkenyl-co-maleimide) can be formed by reacting a poly(alkenyl-co-maleic anhydride) in the presence of ammonia or amines at temperatures from about 100° C. to about 300° C. and at a pressure from about slightly above vacuum to about 2000 kPa, under substantially dry conditions. Alternatively, the poly(alkenyl-co-maleic anhydride) may be mixed with a primary amine. The poly(alkenyl-co-maleic anhydride) may be prepared by any means known in the art for forming copolymers. Free radical polymerization is preferred, but other means are contemplated. The individual monomer units may be distributed in any of a random or alternating arrangement along the polymer backbone. Furthermore, the backbone may be linear or branched. The poly(alkeneyl-co-maleic anhydride) and ammonia or amines are preferably dry mixed in the absence of solvents in a suitable mixing apparatus such as a Brabender mixer. Purging the mixer with N2 prior to charging of the reactants can be beneficial. The amines or ammonia may be added in a single charge, or in sequential partial charges into the reactor containing a charge of poly(alkenyl-co-maleic anhydride). Preferably, the amine or ammonia is charged in a ratio of between about 0.8 to 1.0 moles of nitrogen (in the primary amine or ammonia) per monomer contributed units of maleic anhydride in the poly(alkenyl-co-maleic anhydride).
Suitable primary amines include but are not limited to alkyl amines; alkyl benzyl amines; alkyl phenyl amines; alkoxybenzyl amines; allyl aminobenzoates; alkoxy aniline; and other linear primary amines containing from 1 to about 50 carbon atoms, preferably about 6 to about 30 carbon atoms in the alkyl and alkoxy substituents in these primary amines. The alkyl and alkoxy substituents of the primary amines can be linear or branched, preferably linear, and saturated or unsaturated, preferably saturated. Exemplary amines include hexylamine, octylamine, and dodecylamine. Ammonia is the most preferred nitrogen source due to the improved solubility of the resulting product in the electrolyte solutions. The poly(alkenyl-co-maleimide) preferably has a weight-average molecular weight (Mw) between about 10,000 and 500,000, more typically between about 150,000 and 450,000.
After formation of the copolymers, they are dispersed in a non-polar solvent, such as a hydrocarbon solvent, leading to the formation of a micellar solution. Suitable solvents include aliphatic hydrocarbons, such as pentane, hexane, heptane, octane, nonane, decane, and the like, as well as alicyclic hydrocarbons, such as cyclohexane, methyl cyclopentane, cyclooctane, cyclopentane, cycloheptane, cyclononane, cyclodecane and the like. These hydrocarbons may be used individually or in combination.
With respect to the monomers and solvents identified herein, nano-sized micelle particles are formed by maintaining a temperature that is favorable to micelle formation in the selected solvent(s). More particularly, by maintaining suitable conditions, the nanoparticles will begin to form in the shape of micelles wherein the polar constituents of the copolymer chains, e.g., maleimide, preferentially form the center of the micelle and the non-polar constituents of the copolymer chains, e.g., the alkyl side chains radiate, outwardly therefrom. Exemplary temperatures for the polymers discussed herein are in the range of about −40 to 250° C., with a temperature in the range of about 0 to 150° C. being particularly preferred. As demonstrated in more detail below, the interaction of copolymer selection, temperature, and solvent facilitates the formation of the micelles and ultimately the desired nanoparticles.
Metal Nanocomposite Formation
Nano-sized micelle particles produced in accordance with the present invention may be advantageously utilized as templates in the formation of nano-sized metal nanocomposites and metal/inorganic crystals. The formation of metal nanocomposites is preferably carried out by exposing the nanoparticles to metal ions, preferably metal ions in solution. The metal ion is then complexed with imine groups located inside the nanoparticle. Nano-sized metal/inorganic crystals are formed by introducing a suitable agent, e.g. H2S, CO32− and etc., which may react with the metal ions to form crystals within the micelle particles. Advantageously, the condensed nature of the nanoparticles may restrict the growth of the metal nanocomposites, thus providing size control of the metal nanocomposites into nano-scales.
Metals contemplated for use in the present invention include those known in the art as useful in semiconductors, catalysts, magnetic and quantum dots etc., including but not limited to Cu, Ti, Fe, Cd, Ni, Pd, and mixtures thereof. The formation of the metal nanocomposites is preferably carried out at a temperature of between about 0 and 100° C., more preferably between about 0 and 50° C. Preferred solvents useful in the formation include toluene, tetrahydrofuran (“THF”), water, alcohol, and mixtures thereof.
Separation of the metal nano-composites from the nanocomposites is achieved by performing a solvent change. For example, a solvent in which the polymer chains within the nanoparticles are soluble may be utilized. Such a solvent would induce swelling, and possibly dissolving, of the nanoparticles, thus allowing separation of the nano-sized metal/inorganic crystals from the nanoparticles. Preferred solvents for the separation step include THF, HCCl3, CCl4, toluene, and mixtures thereof.
Nano-sized metal/inorganic crystals produced in accordance with the present invention preferably have a mean average diameter less than about 50 nm, more preferably less than about 20 nm, and most preferably less than about 10 nm.
Of course, the present inventive nano-sized metal/inorganic crystals are suited to applications including the medical field, e.g. drug delivery and blood applications, information technology, e.g. quantum computers and dots, aeronautical and space research, energy, e.g., oil refining and lubricants, and tire applications such as snow/wet traction improvements.
The following examples are provided to help illustrate the present invention. The examples are not provided to limit the scope of the invention defined by the appended claims.
A N2 purged Brabender mixer (˜310 g capacity) equipped with Banbury blades was set to 10 rpm and 30° C. The mixer was then charged with 120 g of poly(maleimide-alt-isobutylene) (Kuraray, commercial name IM-10, Mn=350 K) and 99.4 g of octyl amine (Aldrich, 99% purity). The mixture was agitated in the mixer for 10 minutes and then heated up at a rate about 10° C./min to 210° C. Once the temperature reached 125° C., agitation was stopped. After reaching a temperature of 210° C., the heating element was set to the isothermal condition. The agitation was then started and increased from 0 to 90 rpm at a rate of 10 rpm/min. Once the agitation speed reached 90 rpm, the temperature was set to 190° C. The mixing was continued isothermally for an additional 90 minutes, the heating element was then turned off and the polymer was allowed to cool down at a rate ˜4° C./min. The final product was removed from the mixer at 160° C.
The experiment and the procedure of example 1 were repeated, except for a minor change of the chemicals used. The mixer was charged with 100 g of poly(maleimide-alt-isobutylene) (Kuraray, commercial name IM-10, Mn=350 K) and 118.8 g of dodecyl amine (Aldrich, 95% purity).
A nitrogen purged Brabender mixer (˜310 g capacity) equipped with Banbury blades was set to 20 rpm and 60° C. The mixer was charged with 85 g of poly(maleimide-alt-isobutylene) (Kuraray, commercial name IM-10, Mn=350 K) and 146.8 g of octadecyl amine (Aldrich, 99% purity). The mixture was agitated in the mixer for 10 minutes and then heated up at a rate about 10° C./min to 200° C. Once the temperature reached 135° C., agitation was stopped. When the temperature reached 200° C., the heating element was set to the isothermal condition. The agitation was then started and increased from 0 to 120 rpm at a rate of 10 rpm/min. The mixing was continued isothermally for additional 160 minutes, the heating element was then turned off and the polymer was allowed to cool down at a rate ˜4° C./min. The final product was removed from the mixer at 160° C.
IR characteristic absorption peaks are 1701, 1770, 2855, 2926 cm−1. No trace of maleic anhydride absorption peaks (i.e., at 1779 and 1855 cm−1) and amino-group peaks (i.e., at 3330) were detected for these copolymers. The molecular weights of these products were measured by GPC in THF solution, using polystyrene as the standard. The results are listed below:
Use of Alkylmaleimide Copolymers for Nano-Tech
Two 40 mL bottles were charged with materials as described below. The bottles were named as bottles A and B, respectively. The material inside those bottles was named accordingly as material A and B.
A) 0.2009 g of the products from example 3 were added into 10.056 g dodecane solvent. After being stirred overnight, the alkylmaleimide copolymer was dissolved. The solution was highly translucent and colorless. The solution was then further diluted with addition additional 10.2 g of dodecane. The concentration of the solution was about 1%.
B) 0.5 g of CuAc2 was added into a 15 g of THF. After vigorous stirring for half hour, the CuAc2 was dissolved. The solution was highly translucent to light and was dark blue in color.
The material in bottle A was then charged with 1.0 mL of solution from bottle B. The resulting solution was light blue. Half of the solution was placed in a vacuum oven at 100° C. Further drying of the product under vacuum yielded a polymer-Cu complex film. The film was dark blue, but transparent to light, indicating that the size of Cu++ clusters in the film was in the nano-meter range.
H2S gas was bubbled through the remaining solution in bottle A to fully convert the Cu++ ions to CuS. The solution was then purged with N2 to remove the excess of H2S. The resulting solution is dark colored, with no macroscopic precipitation of CuS from solution. This indicated that the CuS formed are nano-sized and remain within the nanoparticle. (If taking a pure dodecane solvent and then charging with the same amount of Cu++/THF solution, one would find that there was a macroscopic precipitation of CuS from the solution once bubbling H2S through the solution.) Finally, the CuS/polymer solution was placed in a vacuum oven at 100° C. Further drying of the product under vacuum yielded a polymer/nano-sized CuS composite. The material was black, but highly translucent to light.
About 1 mL of the CuS/polymer solution, prepared according to example 5, was further diluted to 50 times with hexane solvent. A drop of the diluted solution was then coated on a graphed copper micro-grid. After the solvent was evaporated, the screen was examined by TEM (
About 1 mL of the CuS/polymer solution, prepared according to example 5, was further diluted to 50 times with THF solvent. THF is known as a good solvent for alkylmaleimide copolymers. Once THF was added, the CuS nano-crystals aggregated and precipitated. After filtrated, a small amount of the CuS was re-dispersed into THF by ultrasound. A drop of the diluted solution was then coated on a graphed copper micro-grid. After the solvent was evaporated, the screen was examined by TEM (
The invention has been described with reference to the exemplary embodiments. Modifications and alterations will occur to others upon reading and understanding the specification. The invention is intended to include such modifications and alterations insofar as they come within the scope of the disclosure and claims.
This application is a divisional of U.S. application Ser. No. 10/872,731, filed on Jun. 21, 2004 now abandoned. This prior application, is hereby incorporated into the present application by reference.
Number | Name | Date | Kind |
---|---|---|---|
2531396 | Carter et al. | Nov 1950 | A |
3598884 | Wei | Aug 1971 | A |
3793402 | Owens | Feb 1974 | A |
3840620 | Gallagher | Oct 1974 | A |
3972963 | Schwab et al. | Aug 1976 | A |
4075186 | Ambrose et al. | Feb 1978 | A |
4233409 | Bulkley | Nov 1980 | A |
4247434 | Vanderhoff et al. | Jan 1981 | A |
4248986 | Lal et al. | Feb 1981 | A |
4326008 | Rembaum | Apr 1982 | A |
4386125 | Shiraki et al. | May 1983 | A |
4463129 | Shinada et al. | Jul 1984 | A |
4471093 | Furukawa et al. | Sep 1984 | A |
4543403 | Isayama et al. | Sep 1985 | A |
4598105 | Weber et al. | Jul 1986 | A |
4602052 | Weber et al. | Jul 1986 | A |
4659790 | Shimozato et al. | Apr 1987 | A |
4717655 | Fluwyler | Jan 1988 | A |
4725522 | Breton et al. | Feb 1988 | A |
4764572 | Bean, Jr. | Aug 1988 | A |
4773521 | Chen | Sep 1988 | A |
4774189 | Schwartz | Sep 1988 | A |
4788254 | Kawakubo et al. | Nov 1988 | A |
4829130 | Licchelli et al. | May 1989 | A |
4829135 | Gunesin et al. | May 1989 | A |
4837274 | Kawakubo et al. | Jun 1989 | A |
4837401 | Hirose et al. | Jun 1989 | A |
4861131 | Bois et al. | Aug 1989 | A |
4870144 | Noda et al. | Sep 1989 | A |
4871814 | Gunesin et al. | Oct 1989 | A |
4904730 | Moore et al. | Feb 1990 | A |
4904732 | Iwahara et al. | Feb 1990 | A |
4906695 | Blizzard et al. | Mar 1990 | A |
4920160 | Chip et al. | Apr 1990 | A |
4942209 | Gunesin | Jul 1990 | A |
4987202 | Zeigler | Jan 1991 | A |
5036138 | Stamhuis et al. | Jul 1991 | A |
5066729 | Srayer, Jr. et al. | Nov 1991 | A |
5073498 | Schwartz et al. | Dec 1991 | A |
5075377 | Kawabuchi et al. | Dec 1991 | A |
5120379 | Noda et al. | Jun 1992 | A |
5130377 | Trepka et al. | Jul 1992 | A |
5169914 | Kaszas et al. | Dec 1992 | A |
5194300 | Cheung | Mar 1993 | A |
5219945 | Dicker et al. | Jun 1993 | A |
5227419 | Moczygemba et al. | Jul 1993 | A |
5237015 | Urban | Aug 1993 | A |
5241008 | Hall | Aug 1993 | A |
5247021 | Fujisawa et al. | Sep 1993 | A |
5256736 | Trepka et al. | Oct 1993 | A |
5262502 | Fujisawa et al. | Nov 1993 | A |
5290873 | Noda et al. | Mar 1994 | A |
5290875 | Moczygemba et al. | Mar 1994 | A |
5290878 | Yamamoto et al. | Mar 1994 | A |
5296547 | Nestegard et al. | Mar 1994 | A |
5329005 | Lawson et al. | Jul 1994 | A |
5331035 | Hall | Jul 1994 | A |
5336712 | Austgen, Jr. et al. | Aug 1994 | A |
5362794 | Inui et al. | Nov 1994 | A |
5395891 | Obrecht et al. | Mar 1995 | A |
5395902 | Hall | Mar 1995 | A |
5399628 | Moczygemba et al. | Mar 1995 | A |
5399629 | Coolbaugh et al. | Mar 1995 | A |
5405903 | Van Westrenen et al. | Apr 1995 | A |
5421866 | Stark-Kasley et al. | Jun 1995 | A |
5436298 | Moczygemba et al. | Jul 1995 | A |
5438103 | DePorter et al. | Aug 1995 | A |
5447990 | Noda et al. | Sep 1995 | A |
5462994 | Lo et al. | Oct 1995 | A |
5514734 | Maxfield et al. | May 1996 | A |
5514753 | Ozawa et al. | May 1996 | A |
5521309 | Antkowiak et al. | May 1996 | A |
5525639 | Keneko et al. | Jun 1996 | A |
5527870 | Maeda et al. | Jun 1996 | A |
5530052 | Takekoshi et al. | Jun 1996 | A |
5580925 | Iwahara et al. | Dec 1996 | A |
5587423 | Brandstetter et al. | Dec 1996 | A |
5594072 | Handlin, Jr. et al. | Jan 1997 | A |
5614579 | Roggeman et al. | Mar 1997 | A |
5627252 | De La Croi Habimana | May 1997 | A |
5674592 | Clark et al. | Oct 1997 | A |
5686528 | Wills et al. | Nov 1997 | A |
5688856 | Austgen, Jr. et al. | Nov 1997 | A |
5707439 | Takekoshi et al. | Jan 1998 | A |
5728791 | Tamai et al. | Mar 1998 | A |
5733975 | Aoyama et al. | Mar 1998 | A |
5739267 | Fujisawa et al. | Apr 1998 | A |
5742118 | Endo et al. | Apr 1998 | A |
5747152 | Oka et al. | May 1998 | A |
5763551 | Wunsch et al. | Jun 1998 | A |
5773521 | Hoxmeier et al. | Jun 1998 | A |
5777037 | Yamanaka et al. | Jul 1998 | A |
5811501 | Chiba et al. | Sep 1998 | A |
5834563 | Kimura et al. | Nov 1998 | A |
5847054 | McKee et al. | Dec 1998 | A |
5849847 | Quirk | Dec 1998 | A |
5855972 | Kaeding | Jan 1999 | A |
5883173 | Elspass et al. | Mar 1999 | A |
5891947 | Hall et al. | Apr 1999 | A |
5905116 | Wang et al. | May 1999 | A |
5910530 | Wang et al. | Jun 1999 | A |
5955537 | Steininger et al. | Sep 1999 | A |
5986010 | Clites et al. | Nov 1999 | A |
5994468 | Wang et al. | Nov 1999 | A |
6011116 | Aoyama et al. | Jan 2000 | A |
6020446 | Okamoto et al. | Feb 2000 | A |
6025416 | Proebster et al. | Feb 2000 | A |
6025445 | Chiba et al. | Feb 2000 | A |
6060549 | Li et al. | May 2000 | A |
6060559 | Feng et al. | May 2000 | A |
6087016 | Feeney et al. | Jul 2000 | A |
6087456 | Sakaguchi et al. | Jul 2000 | A |
6106953 | Zimmermann et al. | Aug 2000 | A |
6117932 | Hasegawa et al. | Sep 2000 | A |
6121379 | Yamanaka et al. | Sep 2000 | A |
6127488 | Obrecht et al. | Oct 2000 | A |
6147151 | Fukumoto et al. | Nov 2000 | A |
6166855 | Ikeyama et al. | Dec 2000 | A |
6180693 | Tang et al. | Jan 2001 | B1 |
6191217 | Wang et al. | Feb 2001 | B1 |
6197849 | Zilg et al. | Mar 2001 | B1 |
6204354 | Wang et al. | Mar 2001 | B1 |
6207263 | Takematsu et al. | Mar 2001 | B1 |
6225394 | Lan et al. | May 2001 | B1 |
6252014 | Knauss | Jun 2001 | B1 |
6255372 | Lin et al. | Jul 2001 | B1 |
6268451 | Faust et al. | Jul 2001 | B1 |
6277304 | Wei et al. | Aug 2001 | B1 |
6348546 | Hiiro et al. | Feb 2002 | B2 |
6359075 | Wollum et al. | Mar 2002 | B1 |
6379791 | Cernohous et al. | Apr 2002 | B1 |
6383500 | Wooley et al. | May 2002 | B1 |
6395829 | Miyamoto et al. | May 2002 | B1 |
6420486 | DePorter et al. | Jul 2002 | B1 |
6437050 | Krom et al. | Aug 2002 | B1 |
6441090 | Demirors et al. | Aug 2002 | B1 |
6448353 | Nelson et al. | Sep 2002 | B1 |
6489378 | Sosa et al. | Dec 2002 | B1 |
6524595 | Perrier et al. | Feb 2003 | B1 |
6573313 | Li et al. | Jun 2003 | B2 |
6573330 | Fujikake et al. | Jun 2003 | B1 |
6598645 | Larson | Jul 2003 | B1 |
6649702 | Rapoport et al. | Nov 2003 | B1 |
6663960 | Murakami et al. | Dec 2003 | B1 |
6689469 | Wang et al. | Feb 2004 | B2 |
6693746 | Nakamura et al. | Feb 2004 | B1 |
6706813 | Chiba et al. | Mar 2004 | B2 |
6706823 | Wang et al. | Mar 2004 | B2 |
6727311 | Ajbani et al. | Apr 2004 | B2 |
6737486 | Wang | May 2004 | B2 |
6750297 | Yeu et al. | Jun 2004 | B2 |
6759464 | Ajbani et al. | Jul 2004 | B2 |
6774185 | Hergenrother et al. | Aug 2004 | B2 |
6777500 | Lean et al. | Aug 2004 | B2 |
6780937 | Castner | Aug 2004 | B2 |
6835781 | Kondou et al. | Dec 2004 | B2 |
6858665 | Larson | Feb 2005 | B2 |
6861462 | Parker et al. | Mar 2005 | B2 |
6872785 | Wang et al. | Mar 2005 | B2 |
6875818 | Wang | Apr 2005 | B2 |
6908958 | Maruyama et al. | Jun 2005 | B2 |
6956084 | Wang et al. | Oct 2005 | B2 |
7056840 | Miller et al. | Jun 2006 | B2 |
7071246 | Xie et al. | Jul 2006 | B2 |
7112369 | Wang et al. | Sep 2006 | B2 |
7179864 | Wang | Feb 2007 | B2 |
7193004 | Weydert et al. | Mar 2007 | B2 |
7205370 | Wang et al. | Apr 2007 | B2 |
7217775 | Castner | May 2007 | B2 |
7238751 | Wang et al. | Jul 2007 | B2 |
7244783 | Lean et al. | Jul 2007 | B2 |
7291394 | Winkler et al. | Nov 2007 | B2 |
7347237 | Xie et al. | Mar 2008 | B2 |
7408005 | Zheng et al. | Aug 2008 | B2 |
20010053813 | Konno et al. | Dec 2001 | A1 |
20020007011 | Konno et al. | Jan 2002 | A1 |
20020045714 | Tomalia et al. | Apr 2002 | A1 |
20020095008 | Heinrich et al. | Jul 2002 | A1 |
20020144401 | Nogueroles Vines et al. | Oct 2002 | A1 |
20030004250 | Ajbani et al. | Jan 2003 | A1 |
20030032710 | Larson | Feb 2003 | A1 |
20030124353 | Wang et al. | Jul 2003 | A1 |
20030130401 | Lin et al. | Jul 2003 | A1 |
20030149185 | Wang et al. | Aug 2003 | A1 |
20030198810 | Wang et al. | Oct 2003 | A1 |
20030225190 | Borbely et al. | Dec 2003 | A1 |
20040033345 | Dubertret et al. | Feb 2004 | A1 |
20040059057 | Swisher et al. | Mar 2004 | A1 |
20040091546 | Johnson et al. | May 2004 | A1 |
20040127603 | Lean et al. | Jul 2004 | A1 |
20040143064 | Wang | Jul 2004 | A1 |
20040198917 | Castner | Oct 2004 | A1 |
20050101743 | Stacy et al. | May 2005 | A1 |
20050182158 | Ziser et al. | Aug 2005 | A1 |
20050192408 | Wang et al. | Sep 2005 | A1 |
20050197462 | Wang et al. | Sep 2005 | A1 |
20050203248 | Zheng et al. | Sep 2005 | A1 |
20050215693 | Wang et al. | Sep 2005 | A1 |
20050228072 | Winkler et al. | Oct 2005 | A1 |
20050228074 | Warren et al. | Oct 2005 | A1 |
20050282956 | Wang et al. | Dec 2005 | A1 |
20060084722 | Bohm et al. | Apr 2006 | A1 |
20060173115 | Fudemoto et al. | Aug 2006 | A1 |
20060173130 | Wang et al. | Aug 2006 | A1 |
20060235128 | Wang et al. | Oct 2006 | A1 |
20070027264 | Wang et al. | Feb 2007 | A1 |
20070135579 | Obrecht et al. | Jun 2007 | A1 |
20070142550 | Scurati et al. | Jun 2007 | A1 |
20070142559 | Wang et al. | Jun 2007 | A1 |
20070149649 | Wang et al. | Jun 2007 | A1 |
20070161754 | Wang et al. | Jul 2007 | A1 |
20070185273 | Wang et al. | Aug 2007 | A1 |
20070196653 | Hall et al. | Aug 2007 | A1 |
20080145660 | Wang et al. | Jun 2008 | A1 |
20080149238 | Kleckner et al. | Jun 2008 | A1 |
20080160305 | Warren et al. | Jul 2008 | A1 |
20080188579 | Wang et al. | Aug 2008 | A1 |
20080286374 | Wang et al. | Nov 2008 | A1 |
20090005491 | Warren | Jan 2009 | A1 |
20090048390 | Wang et al. | Feb 2009 | A1 |
20090054554 | Wang et al. | Feb 2009 | A1 |
20090270558 | Gandon-pain et al. | Oct 2009 | A1 |
20100004398 | Wang et al. | Jan 2010 | A1 |
20100016472 | Wang et al. | Jan 2010 | A1 |
20100016512 | Wang et al. | Jan 2010 | A1 |
Number | Date | Country |
---|---|---|
2127919 | Mar 1995 | CA |
3434983 | Apr 1986 | DE |
4241538 | Jun 1994 | DE |
0143500 | Jun 1985 | EP |
0255170 | Feb 1988 | EP |
0265142 | Apr 1988 | EP |
0322905 | Jul 1989 | EP |
0352042 | Jan 1990 | EP |
0472344 | Feb 1992 | EP |
0540942 | May 1993 | EP |
0590491 | Apr 1994 | EP |
0742268 | Nov 1996 | EP |
1031605 | Aug 2000 | EP |
1099728 | May 2001 | EP |
1134251 | Sep 2001 | EP |
1273616 | Jan 2003 | EP |
1321489 | Jun 2003 | EP |
1783168 | May 2007 | EP |
2099645 | Mar 1972 | FR |
01279943 | Jan 1989 | JP |
2191619 | Jul 1990 | JP |
2196893 | Aug 1990 | JP |
05132605 | May 1993 | JP |
06248017 | Sep 1994 | JP |
7011043 | Jan 1995 | JP |
08199062 | Aug 1996 | JP |
2000-514791 | Nov 2000 | JP |
2003-095640 | Apr 2003 | JP |
2006-072283 | Mar 2006 | JP |
2006-106596 | Apr 2006 | JP |
2007-304409 | Nov 2007 | JP |
9104992 | Apr 1991 | WO |
9704029 | Feb 1997 | WO |
9853000 | Nov 1998 | WO |
0075226 | Dec 2000 | WO |
0187999 | Nov 2001 | WO |
0231002 | Apr 2002 | WO |
02471987 | May 2002 | WO |
0281233 | Oct 2002 | WO |
02100936 | Dec 2002 | WO |
03032061 | Apr 2003 | WO |
03085040 | Oct 2003 | WO |
2004058874 | Jul 2004 | WO |
2006069793 | Jul 2006 | WO |
2008014464 | Jan 2008 | WO |
2008079276 | Jul 2008 | WO |
2008079807 | Jul 2008 | WO |
2009006434 | Jan 2009 | WO |
Number | Date | Country | |
---|---|---|---|
20080305336 A1 | Dec 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10872731 | Jun 2004 | US |
Child | 12047896 | US |